Glycomics or Glycobiology is the study of structure, biology, and function of saccharides which are widely distributed in nature and regarded as glycans as well. Glycans are found in all living organisms. Glycobiology is a rapidly progressing biological area of interest for various fields like biotechnology, biomedicine, and basic research. Most proteins are revised after the translation process in eukaryotic cells. The attachment of glycans is one of the most usual modifications for cell viability. There are two forms of glycosylation 1) N-linked glycosylation: when glycan is attached to asparagines 2) O-linked glycosylation: when the glycan is attached to a serine or threonine.
Glycobiology has a vast range of applicability like diagnostics, oncology, drug discovery & development, immunology, and various other applications. Glycomics is a widely emerging scientific field highlighting on defining functional aspects of glycans in biosystems.
COVID-19 scenario analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.
Owing to such factors, COVID 19 is expected to have a significant impact on glycomics / glycobiology market.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
Rising investments in research and development of pharmaceutical and biotechnology companies and growth in the proteomics market are the major factors boosting glycomics / glycobiology market. Developing countries are providing profitable chances for other companies operating in this field. We are also witnessing technological advancements due to various investments in research by various governments and development in drugs by biotechnology and pharmaceutical companies are helping the growth. Additionally, we are also seeing glycomics and proteomics research studies interest increasing which is expected to propel market expansion shortly.
Different organizations have started academic researches to develop new glycomics and glycobiology tools. Procedures like protein characterizations are advancing due to innovations, such as High-Performance Liquid Chromatography (HPLC), and Mass Spectrometry (MS) in chemical and biochemical research. These techniques are providing rapid and highly sensitive results.
An increase in the demand for medicines for the treatment of several severe chronic diseases is also expected to flourish glycomics / glycobiology market growth.
On the other side, the high cost of tools is expected to hamper the market growth to a certain extent.
New product launches to flourish the market:
On June 4, 2018, Shimadzu Corp. and PREMIER Biosoft, introduced its LCMS-9030 Quadruple Time of Flight (Q-TOF) mass spectrometry system.
On November 15, 2016, ProZyme, Inc. launched Gly-Q Glycan Analysis System which is an integrated platform which is a user-friendly glycoanalysis.
On June 17, 2019, New England Biolabs and Waters Corporation announced a collaboration to accelerate glycomics research by providing goods and services critical to glycan analysis.
Surge in usage in Pharma and biotechnology companies:
They have been a lot of collaborations between major organizations and research institutes which are supporting the segment expansion. The pharma and biotechnology companies segment are growing due to increase in R&D investments.
There is a wide range of applications in drug discovery and development, cell biology, biomedical research, immunology, and biochemistry which are increasing the demand for glycomics / glycobiology market.
Key benefits of the report:
- This study presents the analytical depiction of the global Glycomics / Glycobiology industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Glycomics / Glycobiology market share.
- The current market is quantitatively analyzed to highlight the global market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global Glycomics / Glycobiology market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Glycomics / Glycobiology Market research report:
- What are the leading market players active in the Glycomics / Glycobiology market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Glycomics / Glycobiology Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Lectenz Bio, New England Biolabs, Merck KGaA, Takara Bio, Agilent Technologies, ProZyme, Waters Corporation, Shimadzu Corporation, Thermo Fisher Scientific Inc., S Bio. |
Loading Table Of Content...
